MetaCap

Who Owns Corvus Pharmaceuticals Stock?

NASDAQ: CRVSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

9.67-0.34 (-3.40%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
83.07%
Institutional holders
245
  • Institutions 83.1%
  • Insiders 3.5%
  • Public and other 13.4%

Who owns Corvus Pharmaceuticals stock?

Institutional investors own about 83.1% of Corvus Pharmaceuticals's shares, spread across 245 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 3.50% of CRVS.

The largest institutional holders are Orbimed Advisors LLC. (8.49%), Blackrock Inc. (8.42%) and State Street Corporation (3.95%). Together, the top 10 institutions control 45.9% of shares outstanding. In their latest filings, 3 of the top 10 institutions increased their CRVS positions and 4 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of CRVS

Corvus Pharmaceuticals top institutional holders
InstitutionShares% HeldChange
Orbimed Advisors LLC.7.17M8.49%0.0%
Blackrock Inc.7.10M8.42%-0.5%
State Street Corporation3.33M3.95%-25.5%
Vanguard Capital Management LLC3.32M3.93%+0.8%
Hood River Capital Management LLC3.31M3.93%+110.8%
Adams Street Partners, LLC3.28M3.88%0.0%
Price (T.Rowe) Associates Inc3.06M3.62%-19.3%
Wellington Management Group, LLP2.85M3.38%+4.4%
Vivo Capital, LLC2.81M3.33%0.0%
Perceptive Advisors Llc2.51M2.98%-5.9%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of CRVS

Corvus Pharmaceuticals top fund holders
FundShares% Held
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.37M2.81%
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF1.81M2.15%
iShares Trust-iShares Russell 2000 ETF1.66M1.97%
Manager Directed Portfolios-Hood River Small-Cap Growth Fund1.59M1.88%
T. Rowe Price New Horizons Fund, Inc.963.96K1.14%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund844.72K1.00%
T. ROWE PRICE QUANTITATIVE Mgmt Fd.S, INC.-T. Rowe Price Integrated U.801.90K0.95%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund742.66K0.88%
T. Rowe Price Health Sciences Fund, Inc.616.39K0.73%
iShares Trust-iShares Russell 2000 Growth ETF597.33K0.71%

Frequently asked questions

Who is the largest shareholder of Corvus Pharmaceuticals?

Orbimed Advisors LLC. is the largest institutional shareholder of CRVS, owning 8.49% of shares outstanding (7.17M shares) as of its latest 13F filing.

What percentage of Corvus Pharmaceuticals is owned by institutions?

Institutions own about 83.1% of CRVS shares and 86.1% of the public float.

How much of Corvus Pharmaceuticals do insiders own?

Insiders, such as officers and directors, own about 3.50% of CRVS shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related